Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.

Myocardial infarcts heal by scar formation because there are no stem cells in myocardium, and because adult myocytes cannot divide and repopulate the wound. We sought to redirect the heart to form skeletal muscle instead of scar by transferring the myogenic determination gene, MyoD, into cardiac granulation (wound repair) tissue. A replication-defective adenovirus was constructed containing MyoD under transcriptional control of the Rous sarcoma virus long terminal repeat. The virus converted cultured cardiac fibroblasts to skeletal muscle, indicated by expression of myogenin and skeletal myosin heavy chains (MHCs). To determine if MyoD could induce muscle differentiation in vivo, we injected 2 x 10(9) or 10(10) pfu of either the MyoD or a control beta-galactosidase adenovirus into healing rat hearts, injured 1 wk previously by freeze-thaw. After receiving the lower viral dose, cardiac granulation tissue expressed MyoD mRNA and protein, but did not express myogenin or skeletal MHC. When the higher dose of virus was administered, double immunostaining showed that cells in reparative tissue expressed both myogenin and embryonic skeletal MHC. No muscle differentiation occurred after beta-galactosidase transfection. Thus, MyoD gene transfer can induce skeletal muscle differentiation in healing heart lesions. Modifications of this strategy might eventually provide new contractile tissue to repair myocardial infarcts.

[1]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[2]  H. Blau,et al.  Effect of cell history on response to helix–loop–helix family of myogenic regulators , 1990, Nature.

[3]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[4]  B. Nadal-Ginard,et al.  Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. , 1994, Science.

[5]  S. Tapscott,et al.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[7]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[8]  B. Wold,et al.  Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. , 1992, Development.

[9]  Robert K. Davis,et al.  The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.

[10]  D. Fischman,et al.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro , 1982, The Journal of cell biology.

[11]  S. Tapscott,et al.  Functional antagonism between c-Jun and MyoD proteins: A direct physical association , 1992, Cell.

[12]  J. Gurdon,et al.  Activation of muscle genes without myogenesis by ectopic expression of MyoD in frog embryo cells , 1990, Nature.

[13]  M. Rudnicki,et al.  Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells. , 1990, Developmental biology.

[14]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[15]  T. J. Templeton,et al.  FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. , 1992, Developmental biology.

[16]  Noel N Kim,et al.  Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts , 1993, Circulation.

[17]  A. Faerman,et al.  Ectopic expression of MyoD1 in mice causes prenatal lethalities , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[18]  F. Graham,et al.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. , 1988, Virology.

[19]  Stephen J. Tapscott,et al.  Positive autoregulation of the myogenic determination gene MyoD1 , 1989, Cell.

[20]  S. Tapscott,et al.  MyoD and the regulation of myogenesis by helix-loop-helix proteins. , 1991, The Journal of clinical investigation.

[21]  I. Nonaka,et al.  Myogenin gene disruption results in perinatal lethality because of severe muscle defect , 1993, Nature.

[22]  L. Leinwand,et al.  Cardiomyopathy in transgenic myf5 mice. , 1996, Circulation research.

[23]  S M Schwartz,et al.  Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.

[24]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[25]  S. Woo,et al.  Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. , 1994, Gene therapy.

[26]  T. Lømo,et al.  Embryonic and neonatal myosin heavy chain in denervated and paralyzed rat skeletal muscle. , 1988, Developmental biology.

[27]  M. Perricaudet,et al.  Widespread long-term gene transfer to mouse skeletal muscles and heart. , 1992, The Journal of clinical investigation.

[28]  Harry Hines Boulevard,et al.  Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. , 1991, Molecular and cellular biology.

[29]  M. Karin,et al.  Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. , 1992, Genes & development.

[30]  R. Vracko,et al.  Fate of nerve fibers in necrotic, healing, and healed rat myocardium. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[31]  S. Hauschka,et al.  Transient neonatal denervation alters the proliferative capacity of myosatellite cells in dystrophic (129ReJdy/dy) muscle. , 1992, Journal of neurobiology.

[32]  P. Anversa,et al.  End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. , 1994, Circulation research.

[33]  E. Olson,et al.  Interplay between proliferation and differentiation within the myogenic lineage. , 1992, Developmental biology.

[34]  Manoel Luis Costa,et al.  MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Parker,et al.  Overexpression of XMyoD or XMyf5 in Xenopus embryos induces the formation of enlarged myotomes through recruitment of cells of nonsomitic lineage. , 1994, Developmental biology.

[36]  R. Vracko,et al.  Myocyte reactions at the borders of injured and healing rat myocardium. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[37]  A. Gown,et al.  Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration , 1995, Nature Genetics.

[38]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Cordon-Cardo,et al.  Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. , 1994, The American journal of pathology.

[40]  C. Naus,et al.  Expression of gap junctions in cultured rat L6 cells during myogenesis. , 1993, Developmental biology.

[41]  W. Funk,et al.  Funk site . binding ( CASTing ) for the myogenin consensus Cyclic amplification and selection of targets , 2022 .

[42]  E. Olson,et al.  bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. , 1994, Genes & development.

[43]  William H. Klein,et al.  Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene , 1993, Nature.

[44]  O. Blaschuk,et al.  Noncoordinate developmental regulation of N‐cadherin, N‐CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  P. White,et al.  The Speed of Healing of Myocardial Infarcts. , 1939, Transactions of the American Clinical and Climatological Association.

[46]  W. Gu,et al.  Molecular cardiomyoplasty: potential cardiac gene therapy for chronic heart failure. , 1995, The Journal of thoracic and cardiovascular surgery.

[47]  R. Ivarie,et al.  Expression of bovine myf5 induces ectopic skeletal muscle formation in transgenic mice , 1993, Molecular and cellular biology.

[48]  J. Florini,et al.  The role of the IGFs in myogenic differentiation. , 1991, Advances in experimental medicine and biology.

[49]  R. Virmani,et al.  In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. , 1993, Circulation research.

[50]  C. Clegg,et al.  Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor , 1987, The Journal of cell biology.

[51]  R. Vracko,et al.  Contractile cells in rat myocardial scar tissue. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[52]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[53]  G. Koh,et al.  Differentiation and long-term survival of C2C12 myoblast grafts in heart. , 1993, The Journal of clinical investigation.

[54]  L. Leinwand,et al.  Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  F. Graham,et al.  Manipulation of adenovirus vectors. , 1991, Methods in molecular biology.

[56]  S. Schiaffino,et al.  Embryonic myosin heavy chain as a differentiation marker of developing human skeletal muscle and rhabdomyosarcoma. A monoclonal antibody study. , 1986, Experimental cell research.